MIT CEO

June 15-16, 2026

Koch Institute at MIT

Longwood Healthcare Leaders MIT CEO brings together key thought leaders across pharma, biotech, government, academia, healthcare, and investing for two days of off-the-record discussion and networking, co-hosted with leaders at MIT. Join us June 15-16 for this not-to-be missed event at MIT’s Koch Institute, co-hosted with MIT leadership including MIT President Sally Kornbluth and Institute Professors Phil Sharp and Bob Langer.

Featured Speakers

Kevin Fitzgerald

CSO

Alnylam



Alan Ginsberg

Head, Global Licensing & BD, New Tas

EMD Serono

Maura Healey

Governor

Massachusetts



Susan Hockfield

President Emerita

MIT



Don Ingber

Founding Director

Wyss Institute at Harvard

Rachid Izzar

Head, Commercialization

Biogen

Ed Kaye

CEO

Aurora Therapeutics



Sally Kornbluth

President

MIT



Bob Langer

Institute Professor

MIT



David Liu

Core Institute Member

Broad Institute



Philippe Lopes-Fernandes

CBO

Ipsen

Fiona Marshall

President, Biomedical Research

Novartis

Brett Monia

CEO

Ionis


Bob Pozen

Senior Fellow, Brookings Institution



Claudine Prowse

Venture Partner

JPM Private Capital



Tarek Rabah

CEO

Otsuka North America





Paul Sekhri

CEO

vTv Therapeutics



Phil Sharp

Institute Professor

MIT




Sarah Sheikh

Head, Neuroscience & Head, Global Development

Takeda

Marc Tessier-Lavigne

CEO

Xaira




 

Discussion Topics

Hear from key stakeholders on some of the most important issues facing the industry today.

BioPharma Pipeline Sourcing

Driving Productivity in R&D

Evolving Dealmaking Landscape

Translating Science into Medicine

Maintaining Patient-Centric Focus

Aligning Priorities with the Board

R&D Collaboration

Developing High-Performing Teams

Accelerating Drug Discovery

Pipeline Prioritization

Positioning for Commercial Success

Global Partnerships: Working Across Borders

Assessing Investment Risk

Existing Pipelines: Maintaining Clinical Progress

Adapting to Funding Environment Constraints

Accelerating Innovation in Women’s Health

Ecosystem of External Innovation

Supporting Research at the Intersection of Policy & Science

Advancing Late-Stage Assets

Building Global Biopharmas

Drug Approvals: Insights, Outlook, and Commitment to Patients

The Evolving Needs of R&D

Capital Formation and Strategic Partnerships

Investment Outlook

Highlights from last year's MIT CEO

Watch highlights from last year's MIT CEO, including interviews with Robert Califf (former Commissioner, FDA), Maura Healey (Governor, Massachusetts), Sally Kornbluth (President, MIT), Eliav Barr (CMO, Merck), Ken Keller (CEO, Daiichi Sankyo, Inc.), Janet Woodcock (former Acting Commissioner, FDA), Miguel Fernandez Alcalde (President, EMD Serono), Jorgen Soberg Petersen (Senior Partner, Novo Holdings), among others.

Longwood Healthcare Leaders hosts semiannual invitation-only industry meetings with thought leaders and decision-makers across government, pharma, biotech, and academia, to discuss areas of collaboration and access to innovation in order to accelerate the translation of discoveries into medicines to help patients. Access is limited. Additional details and registration are online here: www.longwoodhealthcareleaders.com/mitceo

 

Supporters

To learn more about getting involved, contact susan@longwoodhealthcareleaders.com

 
LHCL Logo Transparent.png

#LongwoodHealthcareLeaders #MITCEO

 

Upcoming Events:

MIT CEO: June 15-16, 2026

Boston CEO: November 2-3, 2026

San Francisco CEO: January 9-10, 2027

Miami CEO: March 10-12, 2027

LinkedIn  X